Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin on Q2 2022 Results - Earnings Call Transcript

Bionano Genomics, Inc. (NASDAQ:NASDAQ:BNGO) Q2 2022 Results Conference Call August 04, 2022 04:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive...

Related Keywords

China ,San Diego ,California ,United States ,Spain ,Barcelona ,Comunidad Autonoma De Cataluna ,Spanish ,American ,Christopher Stewart ,Jason Mccarthy ,Erik Holmlin ,Shamanna Kanagal ,Amy Conrad ,Chris Stewart ,Michael Okunewitch ,Company Participants ,Laboratory Developed ,Company Investor Relations ,Bionano Genomics Inc ,Jose Carreras Institute ,Nasdaq ,Cancer Genomics Consortium ,Maxim Group ,American Medical Association ,Laboratory Analysis ,Bionano Genomics ,Conference Call August ,Bionano Genomic Second Quarter ,Results Conference ,Investor Relations ,Saphyr System ,Forward Looking Statements ,Accepted Accounting Principles ,Optical Genome Mapping ,Next Generation Sequencing ,Myelodysplastic Syndrome ,Saphyr Systems ,Spanish Optical Genome Mapping ,Hospital Del Mar ,Long String ,Medical Society ,Laboratory Developed Tests ,Optical Genome ,Proprietary Laboratory Analysis ,Homologous Recombination Deficiency ,